Top FDA official cancels staff to approve failed gene therapy trial

Larger / Dr. Peter Marks, Director of the Center for Biological Evaluation and Research within the Food and Drug Administration on March 18, 2021 in Washington, DC. The Food and Drug Administration (FDA) on Thursday announced expanded approval for a gene therapy to treat Duchenne muscular dystrophy (DMD) — despite the fact that it failed … Read more

seekRNA provides a new route for precise gene editing

Features of the IS1111 and IS110 family. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-49474-9 Scientists at the University of Sydney have developed a gene-editing tool with greater precision and flexibility than the industry standard, CRISPR, which has revolutionized genetic engineering in medicine, agriculture and biotechnology. SeekRNA uses a programmable ribonucleic acid (RNA) array that can directly … Read more